Project Grant R01EY036444
Award Date
8/1/24
Completion Date
7/31/29
Dollars Obligated
$425K
Federal Agency
National Eye Institute
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
The National Eye Institute (NEI) awarded a $488,639 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of Pittsburgh to identify the mechanisms underlying the enhanced virulence of an extensively drug-resistant (XDR) strain of Pseudomonas aeruginosa that has caused a concerning outbreak of keratitis infections. The funding will support research to systematically test the unique virulence factors of this outbreak strain and develop more effective...
The National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), awarded a $300,001 Project Grant to Kineolabs, Inc. in Billerica, MA. The objective of this 1-year grant, which runs from July 1, 2025 to June 30, 2026, is to develop a portable, low-cost line-scan swept-source optical coherence tomography (LS-SS-OCT) imaging system. This system is intended for early detection and monitoring of age-related macular degeneration (AMD), diabetic retinopathy, and other eye...
The National Eye Institute (NEI) awarded a $974,348 Project Grant under the Vision Research program (CFDA 93.867) to Wayne State University to conduct research on metabolic signatures in the vitreous of patients with bacterial and fungal endophthalmitis. The research aims to identify potential biomarkers for diagnosing endophthalmitis and guiding appropriate antimicrobial therapy. Specifically, the project will perform untargeted metabolomics analysis on vitreous samples from culture-positive...
This Project Grant award of $869,528 from the National Eye Institute (NEI), part of the NIH Vision Research program (CFDA 93.867), aims to develop an Automated Quantitative Ulcer Analysis (AQUA) algorithm and a point-of-care decision tool to rapidly identify the causative organism type in cases of microbial keratitis, a leading cause of worldwide blindness. The project has four key objectives: 1) Identify risk factors associated with organism types, 2) Create and validate a novel machine...
This $201,825 Project Grant award from the National Eye Institute (NEI) Vision Research program (CFDA 93.867) supports research to evaluate the use of condensin inhibitors as a potential topical treatment for Pseudomonas aeruginosa bacterial eye infections. The lead investigator, Dr. Valentin Rybenkov at the University of Oklahoma, will collaborate with Dr. Michelle Callegan at the University of Oklahoma Health Sciences Center to conduct in vivo studies examining the toxicity, corneal...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) to New York University School of Medicine provides $673,747 to develop a visible-to-near-infrared spanning optical coherence tomography (OCT) system capable of imaging retinal structures at a resolution of up to 0.5 microns. The goal is to leverage this advanced OCT technology to study the spatiotemporal relationship of key biomarkers such as macular pigments and retinal pigment epithelium melanosomes, and...
This Project Grant award from the National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), will fund research to understand the genetic causes of inherited retinal degenerations (IRDs), a group of rare blinding diseases. The $1,369,782 award to the Massachusetts Eye and Ear Infirmary will support two key research aims: Developing a high-throughput splicing assay to identify rare coding and non-coding variants that lead to splicing defects and contribute to the...
This Project Grant award of $1,593,473.00, provided by the National Eye Institute under the Vision Research program (CFDA 93.867), will support a multiomic analysis of preclinical biomarkers for primary open-angle glaucoma (POAG). The study aims to analyze proteomic and metabolomic markers, and their interactions with genetic predisposition, to advance understanding of POAG pathophysiology. Researchers will use plasma samples from a nested case-control group within ongoing prospective cohorts,...
The National Eye Institute (NEI) awarded a $256,296 Project Grant (CFDA 93.867 - Vision Research) to The General Hospital Corporation (Massachusetts General Hospital) to develop new "Auto-Sensing, Instantaneous Adaptive Ranging Optical Coherence Tomography (OCTA)" technology. This technology aims to expand the imaging depth range of OCTA systems, enabling improved visualization of the critical peripheral retinal microvasculature. The project will leverage advances in integrated...
This federal Project Grant award of $306,118 from the National Eye Institute (CFDA 93.867 - Vision Research) aims to develop a drug screening platform using functional human donor eyes to improve the translation probability of investigational new drugs (INDs) for blinding diseases. The project has two key objectives: Establish novel ex vivo preclinical models for human ocular diseases by restoring and preserving in vivo-like light responsiveness in postmortem human eyes for over 48 hours....